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To better understand the dynamic regulation of optimality in metabolic networks under perturbed
conditions, we reconstruct the energetic-metabolic network in mammalian myocardia using
dynamic ﬂux balance analysis (DFBA). Additionally, we modiﬁed the optimal objective from the
maximization of ATP production to the minimal ﬂuctuation of the proﬁle of metabolite
concentration under ischemic conditions, extending the hypothesis of original minimization of
metabolic adjustment to create a composite modeling approach called M-DFBA. The simulation
results are more consistent with experimental data than are those of the DFBA model, particularly
the retentive predominant contribution of fatty acid to oxidative ATP synthesis, the exact
mechanism of which has not been elucidated and seems to be unpredictable by the DFBA model.
These results suggest that the systemic states of metabolic networks do not always remain optimal,
but may become suboptimal when a transient perturbation occurs. This ﬁnding supports the
relevance of our hypothesis and could contribute to the further exploration of the underlying
mechanism of dynamic regulation in metabolic networks.
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Introduction
Producing a modeling method that permits the formulation of
hypotheses on missing components and unidentiﬁed inter-
actions could lead to an understanding of systemic behaviors
with limited input of dynamics information (Palsson, 2000;
Ideker et al, 2001; Kitano, 2002; Collins et al, 2003; Nicholson
et al, 2004). Metabolic ﬂux analysis is a signiﬁcant effort
towards this goal (Fell, 1996; Schilling et al, 1999). Flux
balance analysis (FBA), a method that assumes that optimal
biological functions are acquired through an evolutionary
process (Ibarra et al, 2002), has been especially promising
(Varma and Palsson, 1994). Able to model an optimal systemic
state based on stoichiometry by integrating a restricted set
of parameters in a system, it has been widely used to rebuild
and analyze behaviors of semicharacterized metabolic net-
works (Edwards and Palsson, 2000; Covert et al, 2001; Ibarra
et al, 2002). Dynamic ﬂux balance analysis (DFBA), a further
development of FBA, has been used to represent dynamic
process of metabolic networks based on the theory of dynamic
optimal control. With the ability to predict the metabolite
concentration, it has been successfully applied to the analysis
of diauxic growth in Escherichia coli (Mahadevan et al, 2002).
However, as FBA and DFBA ignore the possibility that,
under abnormal conditions, metabolic networks may not
immediately regulate towards the optimal objective, the
method of minimization of metabolic adjustment (MOMA)
has been designed based on the hypothesis that perturbed
metabolic ﬂuxesundergoaminimal redistribution(Segre ` et al,
2002). MOMA is considered to be an important improvement
over static FBA for the simulation of perturbed metabolic
networks;sinceitsdevelopment,ithasbeenusedfrequentlyin
modeling mutated metabolic networks (Kauffman et al, 2003;
Stephanopoulos et al, 2004).
Myocardial ischemia can be deﬁned as insufﬁcient myo-
cardial blood ﬂow for a given myocardial energetic demand.
Investigation of the energetic-metabolic network under is-
chemic conditions is important for understanding the patho-
logy of coronary artery disease, which frequently results
in myocardial ischemia. The primary effect of ischemia
is impaired mitochondrial metabolism, resulting in less
ATP formation, and accumulation of lactate in the cell. The
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Article number: 2006.0031oxidation of fatty acids provides 60–90% of the energy for
ATP synthesis in a normal, healthy heart, with the balance
coming from carbohydrates (glucose and lactate). Studies in
mammalians show that under mild and moderate ischemic
conditions,thedominantcontributionoffattyacidtooxidative
ATP synthesis does not alter, even though fatty acid has
a lower efﬁciency in ATP synthesis given limited oxygen
supply (Stanley et al, 1997). The mechanisms responsible for
aggravated insufﬁcient energy production are still unclear.
Previous mechanistic models simulating the energy metabo-
lism in ischemic myocardia (Salem et al, 2002) represented
this phenomenon under the condition of 40% blood ﬂow, but
could not give any relevant explanation.
In this study, we modify the DFBA method with the
MOMA hypothesis, naming the composite modeling approach
M-DFBA. We reconstruct the M-DFBA model of energy
metabolism in ischemic mammalian myocardia to explore
the dynamic process of systemic adjustment under abnormal
conditions. The original MOMA method based on static FBA
does not integrate the information on metabolite concentra-
tions, which represents the characteristics of a systemic state
(Raamsdonk et al, 2001). The transition of the proﬁle of
metabolite concentrations may cause a series of dynamic
processes in the cell, resulting in regulation at a genetic or
metabolic level. Consequently, for the M-DFBA model, we
extend the MOMA hypothesis from a minimal redistribution
of metabolic ﬂuxes to a minimal ﬂuctuation of the proﬁle
of metabolite concentrations in perturbed metabolic net-
works. The resulting model is able to represent the dynamic
regulation of utilization of metabolic substrates for energy
production. The simulations of the M-DFBA model show a
closer correlation to experimental data than do those of the
original DFBA model, in which maximal ATP production is set
as the optimal objective under ischemic conditions. Further-
more, the M-DFBA model describes the phenomenon of
predominant contribution of fatty acids to oxidative ATP
production under mild and moderate ischemic conditions,
which the DFBA model is not able to do. The consistency
between M-DFBA and experimental reports indicates that the
metabolic system does not keep the optimal objective of
maximization of ATP production under transient perturbation,
but rather adopts a minimal regulation of its systemic state.
This ﬁnding may reﬂect a conservative survival response of
life forms undersudden perturbation prior to their making any
adaptations that may be required for long-term evolutionary
survival.
Integrating the MOMA method with DFBA for the ﬁrst time,
this work promotes the signiﬁcance of the MOMA hypothesis
for predicting the reactions of transiently perturbed systems,
which may help deepen understanding of the dynamic
regulations of optimality in myocardial metabolic networks
undergoing environmental perturbations.
Results and discussion
Rebuilding the metabolic network by M-DFBA
method
The following pathways are considered in the model of
myocardial energy metabolism, including glycolysis, fatty
acid oxidation, glycogen oxidation, phosphocreatine syn-
thesis and breakdown, and the TCA cycle. Substrates of
energetic metabolism, such as glucose, fatty acid, lactate
and oxygen, are transported from blood ﬂow into myo-
cardia; glycogen and phosphocreatine act as endogenic
supplements.
Based on the premise that under normal conditions the
energetic-metabolic network in myocardia maximizes ATP
production (Cairns et al, 1998), this complex network
was simpliﬁed according to these rules: priority is placed on
the pathways that contribute most to ATP production;
anaerobic metabolism, as a rescue mechanism, is also
considered, even though it produces less ATP in normal
myocardia than does aerobic metabolism; ﬁnally, metabolic
intermediates, such as pyruvate and acetyl-CoA, are over-
looked in accordance with the modeling rules of DFBA.
Thus, we obtained a simpliﬁed network including eight
crucial pathways involving seven important metabolites
(Figure 1).
v1 : Gluc þ 3:68O2 ! 26:2ATP
v2 : Gluc ! 2Lac þ 2ATP
v3 : FA þ 13:82O2 ! 81:79ATP
v4 : Lac þ 1:84O2 ! 12:1ATP
v5 : PC $ ATP
v6 : Gly þ 3:68O2 ! 26:9ATP
v7 : Gly ! 2Lac þ 2ATP
v8 : Gluc þ ATP ! Gly
We reconstruct the myocardial energetic-metabolic network
using the dynamic optimization approach (DOA), one kind
of formulations within DFBA. As mentioned above, the maxi-
mal ATP production is supposed to be the systemic optimal
objective of normal myocardia (Cairns et al, 1998). While
under ischemic conditions, we modify the optimal objective
by minimizing the ﬂuctuation of the proﬁle of metabolite
concentrations, according to the hypothesis of M-DFBA.
To describe the energy demand in myocardia, a lower limit
constraint of ATP synthesis velocity is required under
ischemicconditions.Thesolutiontothedynamicoptimization
problem is described in the Materials and methods section,
and a simple example of how this algorithm works is provided
in Supplementary information.
Figure 1 Simpliﬁed myocardial energetic-metabolic network, containing eight
crucial pathways involving seven important metabolites (Gluc: glucose; FA: fatty
acid; Gly: glycogen; Lac: lactate; PC: phosphocreatine; Pyr: pyruvate; AcCoA:
acetyl-CoA).
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This M-DFBA model describes the dynamic behaviors of the
metabolic network under normal (F¼1) and ischemic (Fo1)
conditions over 10min, where F represents the blood ﬂow.
According to the extent of ischemia, the modeling conditions
are deﬁned as mild (F¼0.8), moderate (F¼0.6 and 0.4), and
severe (F¼0.2) ischemia, respectively. The inputs of fuels to
the myocardia, such as glucose, free fatty acids, lactate, and
oxygen, are assumed to be inﬁnite, and the concentrations of
them in the blood are assumed to be constant throughout the
simulation (Salem et al, 2002).
Figure 2 shows the principal simulation results. In general,
the metabolite concentration remains almost constant in
normal myocardia; in contrast, during ischemic myocardia
the consumption of both endogenic and exogenic fuels
signiﬁcantly changes, and less ATP is produced (Supplemen-
tary Figure 2). It is noticeable that there are slight local
ﬂuctuations in those curves, which might be attributed to the
presence of a large null space in the process of searching for
Figure 2 The modeling results of the M-DFBA model. (A) Lactate concentration increased during moderate ischemia and continued to rise during severe ischemia.
(B) Fatty acid accumulated. (C, D) Endogenic phosphocreatine and glycogen were consumed to produce ATP under ischemic conditions. (E) During moderate
ischemia, glucose uptake increased, while during severe ischemia it decreased, although it still showed a higher level than normal. (F, H) The uptake of fatty acid and
oxygen decreased; however, under mild and moderate ischemia, considering that ATP production decreases (Supplementary Figure 2), the ratio of fatty acid uptake to
carbohydrate uptake for oxidative ATP synthesis is not actually altered. (G) The input ﬂux of lactate converted to an output ﬂux during moderate and severe ischemia.
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the curves in the present study.
The major modeling results that were consistent with
previous publications are summarized as follows:
(1) Under ischemic conditions, endogenic glycogen and
phosphocreatineareconsumed(Figure2CandD)(Stanley
et al, 1997). The utilization of fatty acid decreases
(Figure 2F) and it accumulates in myocardia (Figure 2B)
(Stanley, 2000; Lee et al, 2004).
(2) Lactate, an exogenic fuel, increases in intracellular
concentration (Figure 2A), reversing from an input ﬂux
to an output ﬂux during the aggravation of ischemia
(Figure 2G) (Pantely et al, 1990; Stanley et al, 1997; Salem
et al, 2002); this occurrence could alleviate the toxicity
of lactate accumulation caused by raised anaerobic meta-
bolism under ischemic conditions.
(3) Under moderate ischemic conditions, glucose uptake
increases (Figure 2E) and oxygen uptake decreases
(Figure 2H) (Salem et al, 2002). However, when ischemia
becomes severe, glucose uptake begins to decrease, while
still remaining at a higher level than normal (Figure 2E)
(Stanley et al, 1997). It seems that although glucose
combustion produces more ATP, it does not continue to
increase to prevent lactate accumulation.
It is noticeable that the M-DFBA model predicts several
phenomena that are more consistent with experimental data
than are the predictions of the DFBA model (see Supplemen-
tary information for details):
(1) Under the condition of 40% blood ﬂow, or moderate
ischemia, the value of lactate concentration in the M-DFBA
model increases up to around 7mmolg
 1 in 10min, which
is much closer to the average experimental data of about
5mmolg
 1 (Arai et al, 1991) than is the approximate value of
20mmolg
 1 in the DFBA model (see Supplementary Figure 4C
and D). Moreover, the velocity of lactate uptake in the
M-DFBA model decreases to  0.6B 0.7mmolg
 1min
 1,
which is fairly consistent with the experimental data of  0.2B
 0.7mmolg
 1min
 1 (Stanley et al, 1994) compared to the
value of  4mmolg
 1min
 1 in the DFBA model (see Supple-
mentary Figure 4A and B). Considering the reliability of
M-DFBA modeling results, we propose that the metabolic net-
work regulates in a mild way with respect to the ﬂux
conﬁguration and metabolite concentration distribution rather
than in an extreme way to meet the optimization.
(2) In theory, glucose is regarded as preferable to fatty
acid for ATP production under ischemic conditions, given
that when 1mol O2 is utilized, glucose combustion produces
6.0mol ATP, while palmitic acid combustion produces 5.2mol
ATP. Consequently, it is puzzling that mild or moderate
ischemia does not actually alter the relative contributions
of fatty acid and carbohydrates to oxidative ATP synthesis
(Stanley, 2000). The DFBA model cannot simulate this
phenomenon; the consumption of fatty acid in the DFBA
model decreases sharply under ischemic conditions and
loses its predominant contribution to energy production (see
Supplementary Figure 1D–F). However, the M-DFBA model
is able to predict the actual dynamics under ischemic
conditions (Figure 2D–F) since the increase in consumption
of both glucose and glycogen and the decreasein consumption
of fatty acid are all much less than that found in the DFBA
model. According to the hypothesis of M-DFBA, we propose
that under ischemic conditions the energetic-metabolic
system does not function according to the optimal objective
of ATP production maximization; rather, without immediately
regulating mechanisms, the system is transferred to a
suboptimal state. It is interesting that an alternative treatment
of ischemia is to inhibit myocardial fatty acid oxidation
and promote carbohydrate oxidation by which the insufﬁ-
ciency of energy production is mitigated (Stanley, 2001; Lee
et al, 2004).
Conclusion
In the present work, we reconstructed the energetic-metabolic
networkinmammalianmyocardiaundernormalandischemic
conditions using the M-DFBA method. The simulation results
are basically supported by the previously published experi-
mental data. We propose that the modiﬁcation of the optimal
objective, from the maximization of ATP production in the
DFBA model to the minimization of metabolite concentration
ﬂuctuation under ischemic conditions in the M-DFBA model,
is the key point of this work. Actually, the biological relevance
of the selection of systemic optimality has always been
questioned, especially for a system under perturbations. Our
resultsshowthatthemetabolicnetworkinmyocardiadoesnot
follow the optimal objective of ATP production maximization
under ischemic conditions, but instead reaches a suboptimal
level of energy production with minimal adjustment with
respect to metabolite concentration distribution, which
extends the MOMA hypothesis. Also, these results may help
us to understand the underlying mechanisms involved in the
dynamic regulation of optimality of myocardial metabolic
networks under ischemic conditions.
Materials and methods
Modeling approach
FBA and DFBA methods
As was described previously (Varma and Palsson, 1994; Kauffman
et al, 2003), the FBA modeling method constrains the capability of a
metabolic network by balancing the metabolic ﬂuxes. When the
network is in a steady state, the mass balances can be described as
follows:
S   V ¼ 0 ð1Þ
where S is the stoichiometric matrix and V is the ﬂux vector.
By imposing the ﬂux constraints, systemic behaviors can be restricted
to an enclosed solution space. Finally, a solution is obtained by
optimizing an objective function, such as the maximumof biomass, or
the minimum production of toxin, using linear programming.
The classical FBA method mentioned above does not take into
account the factors of time and molecular concentration, making it
difﬁcult to represent the dynamic process of the biological system.
Hence, DFBA based on optimal control theory was developed to
remedy these shortcomings (Mahadevan et al, 2002). Currently,
DFBA includes two different formulations: DOA and static opti-
mization-based DFBA approach (SOA). DOA performs with greater
precision than SOA, while SOA is scalable to larger metabolic
networks, in which the number of variables does not increase
exponentially with the scale of a network (Mahadevan et al, 2002).
In need of precision, we chose the DOA to reconstruct the myocardial
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is represented as follows:
Objective ¼ Max
Z
fðxÞdx
s:t:
dX
dt
¼ S   V
LðV;XÞp0
CðV;XÞp0
Xðt0Þ¼X0
ð2Þ
where Objective is the objective function, L(V,X) is the linear
constraints, C(V,X) is the nonlinear constraints, and X0 is the original
concentration of a particular metabolite. The solution to the dynamic
optimization problem with the constraints of a differential-algebraic
equation (DEA) is to parameterize the dynamic equations by an
orthogonal collocation of ﬁnite elements (Cuthrell and Biegler, 1987).
Then, the dynamic optimization problem can be transformed into a
nonlinear programming problem, and solved by the fmincon function
in MATLAB
s6.5 (The MathWorks Inc., Natwick, MA). Mahadevan
et al (2002) introduced the details of this solution process in their
published paper.
The formulation of M-DFBA model
As myocardia continuously exchange metabolic substances with
blood, such as glucose, free fatty acids, and lactate, we used the
following equation to describe the rate of change of metabolite
concentration:
dX
dt
¼ S   V þ FðOutX   &XInXÞð 3Þ
where X is a vector of metabolite concentration, t is the time, S is the
stoichiometric matrix, V is a vector composed of the values of all
reactions and transport ﬂuxes, F is blood ﬂow into myocardia, Outx is
the concentration of a particular fuel in arterial blood, &x is the blood–
tissue partition coefﬁcient, Inx is the fuel concentration in cardiac
myocytes, and F(Outx &xInx) is the ﬂuxof a particular fuel fromblood
ﬂow to cardiac myocytes.
According to the DOA, the M-DFBA formulation of this model is
described in equation (4).
As the concentration of various interior metabolites represents the
characteristic of a systemic state (Raamsdonk et al, 2001), we deﬁne
the minimization of the ﬂuctuation of concentration vector X to be the
optimal objective under ischemic conditions, extending the MOMA
hypothesis. Where N is the number of metabolites in the network,
xi,j represents the value of the concentration of metabolite i on the
time point of orthogonal root j,
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ PN
i¼1 ðxi;j   xi;j 1Þ
2
q
represents the
Euclidean distance between two adjacent orthogonal roots (see
Supplementary Figure 3), d(t) is the Dirac-delta function, and M is
the number of orthogonal roots. The goal is to ﬁnd the vector X such
that the integral of Euclidean distances is minimized.
The stoichiometic matrix of the M-DFBA model is received from the
simpliﬁed network shown in Figure 1. The adjusted stoichiometric
coefﬁcients are calculated based on the data set of ﬂux values (Salem
et al, 2002; Supplementary Table 5). The constraints of the DEA
describe the rate of change of metabolite concentration, where SGluc,
SGly, SFA, SLac,S O2, SPC, and SATP indicate rows of the stoichiometric
matrix associated with glucose, glycogen, fatty acid, lactate, oxygen,
phosphocreatine, and ATP, respectively. X0 is the vector of original
concentration. In addition, three linear constraints of particular ﬂuxes
and molecular concentrations are integrated. The ﬁrst one is
qualitatively estimated to represent the capability of myocardia to
act as an energetic buffer during blood ﬂow reduction, namely, the
concentration of a cellular metabolite will not fall directly to zero
under ischemic conditions. The other two constraints are the
maximum ﬂux values of glucose glycolysis and oxygen utilization,
respectively. Moreover, considering the feedback restraint of pyruvate
dehydrogenase by acetyl-CoA, we constrained the proportion of
pyruvate-to-acetyl-CoA ﬂux to acetyl-CoA-to-CO2 ﬂux. This constraint
indicates that the increase in combustion of fatty acids, which causes
the accumulation of acetyl-CoA will inhibit the oxidation of
carbohydrate (glucose and lactate) in myocardia. Finally, as the
normal optimal objective of ATP production is replaced under
ischemic conditions by minimization of metabolite concentration
ﬂuctuation, a new constraint is required for the purpose of describing
the unaltered requirement of energy in ischemic myocardia. We made
a qualitative estimate of the lower limit constraint of ATP synthesis
velocity to express this energetic demand, where a represents the
normal velocity of ATP consumption (the values of the parameters
used in equation (4) are listed in Supplementary Table 1–5):
Objective ¼ Min
X M
j¼1
Z tf
t0
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X N
i¼1
ðxi;j   xi;j 1Þ
2
v u u t dðt   tjÞdt
s:t:
dxGluc
dt
¼ SGluc   VGluc þ FðOutGluc   &GlucInGlucÞ
dxGly
dt
¼ SGly   VGly
dxFA
dt
¼ SFA   VFA þ FðOutFA   &FAInFAÞ
dxLac
dt
¼ SLac   VLac þ FðOutLac   &LacInLacÞ
dxO2
dt
¼ SO2   VO2 þ FðOutO2   &O2InO2Þ
dxPC
dt
¼ SPC   VPC
dxATP
dt
¼ SATP   VATP
X0 ¼½ xGluc
0 ; x
Gly
0 ; xFA
0 ; xLac
0 ; x
O2
0 ; xPC
0 ; xATP
0  
T
ﬃﬃﬃ
F
p
X0p½xGluc; xGly; xFA; xLac; xO2; xPC; xATP 
T
SGluc   VGlucoVGluc!GP
max
SO2   VO2oVO2!H2O
max
v1 þ v4 þ v6
v1 þ v3 þ v4 þ v6
o0:7175
SATP   VATPXa ð
ﬃﬃﬃ
F
p
þ FÞ=2
ð4Þ
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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